002603 以岭藥業
按盤價 
15.530 +0.480 (+3.189%)
15.530 +0.480 (+3.189%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.652 | 12.129 | -6.686 | 12.085 | 23.626 |
| 總資產報酬率 ROA (%) | 2.936 | 9.532 | -4.783 | 8.118 | 16.158 |
| 投入資產回報率 ROIC (%) | 3.496 | 11.634 | -5.868 | 9.832 | 19.722 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.054 | 64.277 | 50.187 | 57.282 | 63.771 |
| 營業利潤率 (%) | 20.483 | 20.732 | -10.578 | 17.249 | 22.577 |
| 息稅前利潤/營業總收入 (%) | 20.120 | 20.307 | -11.942 | 16.578 | 22.346 |
| 淨利潤/營業總收入 (%) | 16.748 | 16.368 | -11.273 | 13.028 | 18.813 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.779 | 105.628 | 79.280 | 94.947 | 103.068 |
| 價值變動淨收益/利潤總額(%) | 1.063 | 0.377 | -4.975 | 3.877 | 0.414 |
| 營業外收支淨額/利潤總額(%) | -2.176 | -1.999 | 13.909 | -5.677 | -1.759 | 償債能力分析 |
| 流動比率 (X) | 2.502 | 2.358 | 1.663 | 1.472 | 1.496 |
| 速動比率 (X) | 1.921 | 1.684 | 0.993 | 0.919 | 1.079 |
| 資產負債率 (%) | 19.658 | 19.694 | 23.403 | 32.636 | 33.111 |
| 帶息債務/全部投入資本 (%) | 0.738 | -0.387 | -0.443 | 14.733 | 16.356 |
| 股東權益/帶息債務 (%) | 12,908.334 | -24,813.824 | -21,591.475 | 554.734 | 495.085 |
| 股東權益/負債合計 (%) | 408.976 | 408.046 | 327.983 | 206.624 | 202.053 |
| 利息保障倍數 (X) | 275.627 | -1,127.566 | -34.699 | 64.873 | 140.593 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 46.613 | 56.414 | 100.233 | 72.012 | 47.934 |
| 存貨周轉天數 (天) | 130.820 | 208.153 | 233.312 | 182.969 | 146.462 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 23/06/2026 11:26 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
